Literature DB >> 18248624

Parkin mediates the degradation-independent ubiquitination of Hsp70.

Darren J Moore1, Andrew B West, Dustin A Dikeman, Valina L Dawson, Ted M Dawson.   

Abstract

Mutations in the parkin gene cause autosomal recessive, juvenile-onset parkinsonism. Parkin is an E3 ubiquitin ligase that mediates the ubiquitination of protein substrates. Disease-associated mutations cause a loss-of-function of parkin which may compromise the poly-ubiquitination and proteasomal degradation of specific protein substrates, potentially leading to their deleterious accumulation. Here, we identify the molecular chaperones, Hsp70 and Hsc70, as substrates for parkin. Parkin mediates the ubiquitination of Hsp70 both in vitro and in cultured cells. Parkin interacts with Hsp70 via its second RING finger domain and mutations in/near this domain compromise Hsp70 ubiquitination. Ubiquitination of Hsp70 fails to alter its steady-state levels or turnover, nor does it promote its proteasomal degradation. Consistent with this observation, Hsp70 levels remain unaltered in brains from parkin-deficient autosomal recessive, juvenile-onset parkinsonism subjects, whereas alternatively, Hsp70 levels are elevated in the detergent-insoluble fraction of sporadic Parkinson's disease/dementia with Lewy bodies brains. Parkin mediates the multiple mono-ubiquitination of Hsp70/Hsc70 consistent with a degradation-independent role for this ubiquitin modification. Our observations support a novel functional relationship between parkin and Hsc/Hsp70 and support the notion that parkin is a multi-purpose E3 ubiquitin ligase capable of modifying proteins either via attachment of alternatively linked poly-ubiquitin chains or through multiple mono-ubiquitination to achieve alternate biological outcomes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18248624      PMCID: PMC4432938          DOI: 10.1111/j.1471-4159.2008.05261.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  61 in total

1.  Diverse effects of pathogenic mutations of Parkin that catalyze multiple monoubiquitylation in vitro.

Authors:  Noriyuki Matsuda; Toshiaki Kitami; Toshiaki Suzuki; Yoshikuni Mizuno; Nobutaka Hattori; Keiji Tanaka
Journal:  J Biol Chem       Date:  2005-12-08       Impact factor: 5.157

2.  Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.

Authors:  Sathya R Sriram; Xiaojie Li; Han Seok Ko; Kenny K K Chung; Esther Wong; Kah Leong Lim; Valina L Dawson; Ted M Dawson
Journal:  Hum Mol Genet       Date:  2005-07-27       Impact factor: 6.150

3.  Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease.

Authors:  K K Chung; Y Zhang; K L Lim; Y Tanaka; H Huang; J Gao; C A Ross; V L Dawson; T M Dawson
Journal:  Nat Med       Date:  2001-10       Impact factor: 53.440

4.  Parkin ubiquitinates and promotes the degradation of RanBP2.

Authors:  Ji Won Um; Do Sik Min; Hyewhon Rhim; Jongsun Kim; Seung R Paik; Kwang Chul Chung
Journal:  J Biol Chem       Date:  2005-12-06       Impact factor: 5.157

5.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.

Authors:  H Shimura; N Hattori; S i Kubo; Y Mizuno; S Asakawa; S Minoshima; N Shimizu; K Iwai; T Chiba; K Tanaka; T Suzuki
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

6.  Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress.

Authors:  Darren J Moore; Li Zhang; Juan Troncoso; Michael K Lee; Nobutaka Hattori; Yoshikuni Mizuno; Ted M Dawson; Valina L Dawson
Journal:  Hum Mol Genet       Date:  2004-11-03       Impact factor: 6.150

7.  Novel monoclonal antibodies demonstrate biochemical variation of brain parkin with age.

Authors:  Aaron C Pawlyk; Benoit I Giasson; Deepak M Sampathu; Francisco A Perez; Kah Leong Lim; Valina L Dawson; Ted M Dawson; Richard D Palmiter; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Biol Chem       Date:  2003-09-12       Impact factor: 5.157

8.  U-box protein carboxyl terminus of Hsc70-interacting protein (CHIP) mediates poly-ubiquitylation preferentially on four-repeat Tau and is involved in neurodegeneration of tauopathy.

Authors:  Shigetsugu Hatakeyama; Masaki Matsumoto; Takumi Kamura; Miyuki Murayama; Du-Hua Chui; Emmanuel Planel; Ryosuke Takahashi; Keiichi I Nakayama; Akihiko Takashima
Journal:  J Neurochem       Date:  2004-10       Impact factor: 5.372

9.  Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients.

Authors:  H Shimura; N Hattori; S Kubo; M Yoshikawa; T Kitada; H Matsumine; S Asakawa; S Minoshima; Y Yamamura; N Shimizu; Y Mizuno
Journal:  Ann Neurol       Date:  1999-05       Impact factor: 10.422

10.  CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.

Authors:  Hideki Shimura; Daniel Schwartz; Steven P Gygi; Kenneth S Kosik
Journal:  J Biol Chem       Date:  2003-11-10       Impact factor: 5.157

View more
  52 in total

1.  Parkin mono-ubiquitinates Bcl-2 and regulates autophagy.

Authors:  Dong Chen; Feng Gao; Bin Li; Hongfeng Wang; Yuxia Xu; Cuiqing Zhu; Guanghui Wang
Journal:  J Biol Chem       Date:  2010-10-02       Impact factor: 5.157

Review 2.  Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases.

Authors:  Zezong Gu; Tomohiro Nakamura; Stuart A Lipton
Journal:  Mol Neurobiol       Date:  2010-03-25       Impact factor: 5.590

3.  Parkin deficiency disrupts calcium homeostasis by modulating phospholipase C signalling.

Authors:  Anna Sandebring; Nodi Dehvari; Monica Perez-Manso; Kelly Jean Thomas; Elena Karpilovski; Mark R Cookson; Richard F Cowburn; Angel Cedazo-Mínguez
Journal:  FEBS J       Date:  2009-08-03       Impact factor: 5.542

Review 4.  The role of parkin in familial and sporadic Parkinson's disease.

Authors:  Ted M Dawson; Valina L Dawson
Journal:  Mov Disord       Date:  2010       Impact factor: 10.338

Review 5.  Parkin and PINK1 functions in oxidative stress and neurodegeneration.

Authors:  Sandeep K Barodia; Rose B Creed; Matthew S Goldberg
Journal:  Brain Res Bull       Date:  2016-12-23       Impact factor: 4.077

6.  Parkin Regulates Mitosis and Genomic Stability through Cdc20/Cdh1.

Authors:  Seung Baek Lee; Jung Jin Kim; Hyun-Ja Nam; Bowen Gao; Ping Yin; Bo Qin; Sang-Yeop Yi; Hyoungjun Ham; Debra Evans; Sun-Hyun Kim; Jun Zhang; Min Deng; Tongzheng Liu; Haoxing Zhang; Daniel D Billadeau; Liewei Wang; Emilie Giaime; Jie Shen; Yuan-Ping Pang; Jin Jen; Jan M van Deursen; Zhenkun Lou
Journal:  Mol Cell       Date:  2015-09-17       Impact factor: 17.970

7.  Identification and characterization of a novel endogenous murine parkin mutation.

Authors:  Chenere P Ramsey; Benoit I Giasson
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

8.  Genome wide DNA-profiling of HIV-related B-cell lymphomas.

Authors:  Daniela Capello; Marta Scandurra; Giulia Poretti; Paola M V Rancoita; Michael Mian; Annunziata Gloghini; Clara Deambrogi; Maurizio Martini; Davide Rossi; Timothy C Greiner; Wing C Chan; Maurilio Ponzoni; Santiago M Moreno; Miguel A Piris; Vincenzo Canzonieri; Michele Spina; Umberto Tirelli; Giorgio Inghirami; Andrea Rinaldi; Emanuele Zucca; Riccardo D Favera; Franco Cavalli; Luigi Maria Larocca; Ivo Kwee; Antonino Carbone; Gianluca Gaidano; Francesco Bertoni
Journal:  Br J Haematol       Date:  2009-10-12       Impact factor: 6.998

9.  Parkin-mediated ubiquitination regulates phospholipase C-gamma1.

Authors:  Nodi Dehvari; Anna Sandebring; Amilcar Flores-Morales; Laura Mateos; Yin-Choy Chuan; Matthew S Goldberg; Mark R Cookson; Richard F Cowburn; Angel Cedazo-Mínguez
Journal:  J Cell Mol Med       Date:  2008-07-30       Impact factor: 5.310

10.  Parkin is protective against proteotoxic stress in a transgenic zebrafish model.

Authors:  Mareike E Fett; Anna Pilsl; Dominik Paquet; Frauke van Bebber; Christian Haass; Jörg Tatzelt; Bettina Schmid; Konstanze F Winklhofer
Journal:  PLoS One       Date:  2010-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.